Table 8 Antibacterial activity results of compounds (a15–a17)
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Minimum inhibitory concentration (MIC = µg/ml) | ||||
|---|---|---|---|---|---|
Bacterial species | |||||
S. aureus | E. coli | K. pneumoniae | P. aeruginosa | S. pyogenes | |
a15 | 12.5 | 25 | 25 | 25 | 12.5 |
a16 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 |
a17 | 25 | 12.5 | 12.5 | 25 | 12.5 |
Ciprofloxacin | 25 | 25 | 50 | 25 | 12.5 |